Evidence map›Paper›PMID 39225466›Full record

ArticlemSystems2024

Zhenzhen Wang, Shuai Yang, Linglin Tong, Xin Li, Weiyi Mao, Honghua Yuan, Yang Chen, Shenyang Zhang, He Zhang, Renjin Chen

Abstract read
In one paragraph

Article in mSystems, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhenzhen Wang *Cancer Institute, Xuzhou Medical University, Xuzhou, China.
Shuai Yang *College of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China.ORCID 0000-0001-8772-5749
Linglin Tong *College of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Xin Li *College of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Weiyi MaoSchool of Basic Medical Sciences, Nanjing Medical University, Jiangsu, China.
Honghua YuanCollege of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Yang ChenCollege of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Shenyang ZhangDepartment of Neurology, the Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China.ORCID 0000-0001-5968-4134
He ZhangCollege of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China.ORCID 0000-0001-9334-7692
Renjin ChenCollege of Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu, China.ORCID 0000-0003-2754-4211

Funding

| Graduate Research and Innovation Projects of Jiangsu Province (Graduate Research and Innovation Project) KYCX23_2947Jiangsu Province College Students' innovation and entrepreneurship training program 202110313073YJiangsu Province College Students Innovation and Entrepreneurship Training Program 202110313073YKey University Science Research Project of Jiangsu Province 22KJA320005Key University Science Research Project of Jiangsu Province () 22KJA320005Medical Guidance Program of Jiangsu Provincial Health and Wellness Commission and Xuzhou Key R&D Program (Social Development)-Medicine and Health Surface Project. Z2023089, KC23277, KC23262
6 · The paper itself

Abstract

Altered composition of the gut microbiota affects immunity and metabolism. This study previously found that

Indexed as

AtherosclerosisGastrointestinal MicrobiomeInflammationAnimalsDiet, High-FatFemaleHumansLactobacillus acidophilusMaleMiceMice, Inbred C57BLMice, KnockoutPeptide Initiation FactorsPeptide Initiation FactorsatherosclerosiseIF6 genegut microbiotaL. acidophilusmetabolites

Identifiers

PMID39225466
PMCPMC11494895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.